Publicaciones
-
Mora J and Gerald, WL.
Origin of neuroblastic tumors: clues for future therapeutics
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS . 4(3): 293-302. Nº de citas: 26
-
Mora J.
Topotecan sistémico, oral o intratecal en el tratamiento de tumores sólidos pediátricos
FORHOS . 7(3): 38-42.
-
Mora J, Filippa, DA, Qin, J and Wollner, N.
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol -: The 30-year experience at Memorial Sloan-Kettering Cancer Center
CANCER . 98(6): 1283-1291. Nº de citas: 54
-
Alaminos, M, Mora J, Cheung, NKV, Smith, A, Qin, J, Chen, LS and Gerald, WL.
Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma
CANCER RESEARCH . 63(15): 4538-4546. Nº de citas: 75
-
Mora J, Gerald WL and Cheung NK.
Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma
CANCER LETTERS . 197(1-2): 119-124. Nº de citas: 23
-
Mora J, Gerald, WL, Qin, J and Cheung, NKV.
Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma
CANCER . 94(10): 2756-2765. Nº de citas: 25
-
Mora J, Cheung, NKV, Oplanich, S, Chen, LS and Gerald, WL.
Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma
CANCER RESEARCH . 62(6): 1761-1767. Nº de citas: 20
-
Mora J, Cheung, NKV, Juan, G, Illei, P, Cheung, I, Akram, M, Chi, S, Ladanyi, M, Cordon-Cardo, C and Gerald, WL.
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell
CANCER RESEARCH . 61(18): 6892-6898. Nº de citas: 80
-
Mora J, Cheung NK and Gerald WL.
Genetic heterogeneity and clonal evolution in neuroblastoma
BRITISH JOURNAL OF CANCER . 85(2): 182-189. Nº de citas: 39
-
Mora J, Cheung, NKV, Chen, LS, Qin, J and Gerald, W.
Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma
CLINICAL CANCER RESEARCH . 7(5): 1358-1361. Nº de citas: 51